May 23, 2011 — Accelr8 presented results of two studies at ASM 2011 in New Orleans. One reported results with a new 4-hour hVISA test for a threatening new type of Staph resistance. The second study screened ICU patient specimens to successfully detect and identify three leading species of potentially resistant pathogens in 4 hours, directly from specimen. The 3-organism test included the two most important resistance types for each species.
May 16, 2011 — Initial data from pilot study show strong positive results for the BACcel™ rapid system.
Apr 14, 2011 — Industry collaborator exercises option to extend exclusive negotiation period. Two new presentations at ASM2011.
Mar 01, 2011 — Accelr8 Technology Corporation (NYSE Alternext US: AXK) announced that one of its outside principal investigators received acceptance to present results of a new study in Europe.
Feb 22, 2011 — May meeting for Pulmonary Medicine will have a presentation on preliminary results from study at Denver Health with ICU patient specimens. Company also announced start of product engineering to meet early milestones for next product version.